Twin Tree Management, LP Astrazeneca PLC Transaction History
Twin Tree Management, LP
- $22.8 Billion
- Q3 2025
A detailed history of Twin Tree Management, LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Twin Tree Management, LP holds 27,000 shares of AZN stock, worth $2.41 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
27,000
Previous 484,300
94.42%
Holding current value
$2.41 Million
Previous $33.8 Million
93.88%
% of portfolio
0.01%
Previous 0.07%
Shares
26 transactions
Others Institutions Holding AZN
# of Institutions
1,507Shares Held
501MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...